Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report

Lancet

Volumn 368, Issue 9552, 2006, Pages 2061-2067

  Wroe, Stephen J ^a,b   Pal, Suvankar ^a,b   Siddique, Durrenajaf ^a,b   Hyare, Harpreet ^a,b   Macfarlane, Rebecca ^a,b   Joiner, Susan ^b   Linehan, Jacqueline M ^b   Brandner, Sebastian ^b   Wadsworth, Jonathan DF ^b   Hewitt, Patricia ^c   Collinge, John ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEPACRINE; PRION PROTEIN;

ADULT; ANAMNESIS; ARTICLE; AUTOPSY; BIOPSY; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN TISSUE; CASE REPORT; COW; CREUTZFELDT JAKOB DISEASE; DEATH; DETERIORATION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE TRANSMISSION; EXPERIMENTAL THERAPY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IATROGENIC DISEASE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL SPECIALIST; NEUROLOGIC DISEASE; PATIENT REFERRAL; POPULATION EXPOSURE; PRIMARY INFECTION; PRION; PRION DISEASE; PRIORITY JOURNAL; RECIPIENT; RISK ASSESSMENT; SURVIVAL TIME; TONSIL;

EID: 33845227845     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69835-8     Document Type: Article

References (39)

1. Collinge J. Variant Creutzfeldt-Jakob disease. Lancet 354 (1999) 317-323
2. Hill A., Butterworth R., Joiner S., et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353 (1999) 183-189
3. Wadsworth J., Joiner S., Hill A., et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immuno-blotting assay. Lancet 358 (2001) 171-180
4. Hunter N., Foster J., Chong A., et al. Transmission of prion diseases by blood transfusion. J Gen Virol 83 (2002) 2897-2905
5. Llewelyn C., Hewitt P., Knight R., et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363 (2004) 417-421
6. Peden A., Head M., Ritchie D., Bell J., and Ironside J. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364 (2004) 527-529
7. Collinge J. Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry 76 (2005) 906-919
8. Kascsak R., Rubenstein R., Merz P., et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61 (1987) 3688-3693
9. Frosh A., Smith L., Jackson C., et al. Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein. Lancet 364 (2004) 1260-1262
10. MRC Clinical Trials Unit. PRION-1: Randomised trial of quinacrine in human prion disease. http://www.ctu.mrc.ac.uk/studies/cjd.asp (accessed Sept 8, 2006)
11. Collinge J., Sidle K., Meads J., Ironside J., and Hill A. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383 (1996) 685-690
12. Hill A., Joiner S., Wadsworth J., et al. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126 (2003) 1333-1346
13. Will R., Ironside J., Zeidler M., et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347 (1996) 921-925
14. Hill A., Zeidler M., Ironside J., and Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349 (1997) 99-100
15. Collinge J., Whitfield J., McKintosh E., et al. Kuru in the 21st century-an acquired human prion disease with very long incubation periods. Lancet 367 (2006) 2068-2074
16. Heikenwalder M., Zeller N., Seeger H., et al. Chronic lymphocytic inflammation specifies the organ tropism of prions. Science 307 (2005) 1107-1110
17. Hill A., Joiner S., Linehan J., Desbruslais M., Lantos P., and Collinge J. Species barrier independent prion replication in apparently resistant species. Proc Natl Acad Sci USA 97 (2000) 10248-10253
18. Hill A., and Collinge J. Subclinical prion infection. Trends Microbiol 11 (2003) 578-584
19. Asante E., Linehan J., Desbruslais M., et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 21 (2002) 6358-6366
20. Wadsworth J., Asante E., Desbruslais M., et al. Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306 (2004) 1793-1796
21. Bishop M., Hart P., Aitchison L., et al. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 5 (2006) 393-398
22. Asante E., Linehan J., Gowland I., et al. Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice. Proc Natl Acad Sci USA 103 (2006) 10759-10764
23. Hill A., Desbruslais M., Joiner S., et al. The same prion strain causes vCJD and BSE. Nature 389 (1997) 448-450
24. Collie D., Summers D., Sellar R., et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol 24 (2003) 1560-1569
25. Chazot G., Broussolle E., Lapras C., Blattler T., Aguzzi A., and Kopp N. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 347 (1996) 1181
26. Zeidler M., Sellar R., Collie D., et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 355 (2000) 1412-1418
27. Siddique D., Kennedy A., Thomas D., et al. Tonsil biopsy in the investigation of suspected variant Creutzfeldt-Jakob disease-a cohort study of 50 patients. J Neurol Sci 238 (2005) S1-S570
28. Rossetti A., Bogousslavsky J., Glatzel M., and Aguzzi A. Mimicry of variant Creutzfeldt-Jakob disease by sporadic Creutzfeldt-Jakob disease: importance of the pulvinar sign. Arch Neurol 61 (2004) 445-446
29. Mihara M., Sugase S., Konaka K., et al. The "pulvinar sign" in a case of paraneoplastic limbic encephalitis associated with non-Hodgkin's lymphoma. J Neurol Neurosurg Psychiatry 76 (2005) 882-884
30. Yoshimura N., and Soma Y. A case of benign intracranial hypertension with bilateral reversible thalamic lesions on magnetic resonance imaging. Rinsho Shinkeigaku 32 (1992) 327-329
31. Hahn J., Sum J., and Lee K. Unusual MRI findings after status epilepticus due to cat-scratch disease. Pediatr Neurol 10 (1994) 255-258
32. Harding B., Alsanjari N., Smith S., et al. Progressive neuronal degeneration of childhood with liver disease (Alpers' disease) presenting in young adults. J Neurol Neurosurg Psychiatry 58 (1995) 320-325
33. Cusmai R., Bertini E., Di Capua M., et al. Bilateral, reversible, selective thalamic involvement demonstrated by brain MR and acute severe neurological dysfunction with favorable outcome. Neuropediatrics 25 (1994) 44-47
34. Cordery R., Macmanus D., Godbolt A., Rossor M., and Waldman A. Short TE quantitative proton magnetic resonance spectroscopy in variant Creutzfeldt-Jakob disease. Eur Radiol 16 (2006) 1692-1698
35. Hilton D., Sutak J., Smith M., et al. Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol 57 (2004) 300-302
36. Hilton D., Fathers E., Edwards P., Ironside J., and Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 352 (1998) 703-704
37. Hilton D., Ghani A., Conyers L., et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203 (2004) 733-739
38. Health Protection Agency. The National Anonymous Tonsil Archive (NATA). http://www.hpa.org.uk/infections/topics_az/cjd/tonsil_archive.htm (accessed Sept 8, 2006)
39. Mallucci G., and Collinge J. Rational targeting for prion therapeutics. Nat Rev Neurosci 6 (2005) 23-34